财新传媒
财新英文 > 要闻 > 正文

Could U.S. Targeting of Two China Genomics Firms be Related to Huawei?

2019年06月17日 20:10 来源于 财新网
Senators ask Health and Human Services Department to determine if BGI and WuXi NextCODE received federal funds
A BGI laboratory in Kunming, Yunnan province, on Dec. 26, 2018. Photo:IC Photo

A pair of U.S. senators could be seeking a probe of two Chinese genomics firms that may indirectly get federal money due to their ties to embattled telecom equipment maker Huawei, an analyst said, as one firm called for fair treatment and the other played down its Chinese ties.

版面编辑:喻竹杨洋

图片推荐

视听推荐

财新网主编精选版电邮 样例
财新网新闻版电邮全新升级!财新网主编精心编写,每个工作日定时投递,篇篇重磅,可信可引。
订阅